McCarter has decades of experience defending pharmaceutical manufacturers, distributors and retailers in complex, single-plaintiff, mass tort and class action matters pending in federal and state courts. We serve as national, regional, local and issue counsel in litigation involving product liability, medical monitoring claims, federal preemption, the possibility of punitive damages, epidemiological analysis of causation and Daubert (and its state law equivalents) proceedings to exclude dubious expert testimony. The team has litigated numerous bet-the-company cases over statins, antidepressants, antipsychotics, proton pump inhibitors and hormone replacement therapies, to name a few. Our attorneys address scientific, epidemiologic and complex medical issues in class action and multi-jurisdictional litigation. We regularly practice before the Judicial Panel on Multidistrict Litigation and have broad expertise employing creative initial and long-term procedural and substantive dispositive strategies, including strategies to limit initial discovery.
The innovative strategies we employ often result in broad, swift dismissals of otherwise challenging actions. With a deep bench of partners, counsel and associates, McCarter meets client demands without sacrificing quality, timeliness or personal attention. We work with clients' audits of products both before and after launch and counsel on preventative measures and risk management to avoid or limit the need for litigation.
The firm specializes in serving pharmaceutical companies as national discovery counsel. Our decades of experience handling large-scale document and data productions enable us to assist our clients in complying with the increasing burdens of document and electronic data retention. We routinely advise on records management and ESI issues in small actions and large, complex MDL litigations. Our experience includes management of the largest and most compressed ESI pharmaceutical litigation production effort in the history of e-Discovery. We offer a wide range of comprehensive records management and e-Discovery solutions that address risk management and the four stages of the e-Discovery life cycle: preservation, collection, review and production. McCarter possesses unique, substantive industry and legal knowledge as well as technical expertise in e-Discovery. Our team members participate in industry speakers' platforms and think tanks, and also act as policy writers with groups such as the Sedona Conference Working Group, ensuring that we are current on existing law and anticipated trends.